Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Neuroscience Letters|February 16, 2010
Amyloid load in nondemented brains correlates with APOE e4Richard J Caselli, Douglas Walker, Lucia Sue, et al.Molecular Neurodegeneration|June 6, 2009
Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patientsHikmet Nural, Ping He, Thomas Beach, et al.Journal of Alzheimer'S Disease : JAD|March 4, 2011
Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathologyKaori Morimoto, Juri Horio, Haruhisa Satoh, et al.Current Alzheimer Research|October 6, 2012
BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brainsBoris Decourt, Amanda Gonzales, Thomas G Beach, et al.Archives of Neurology|December 19, 2006
Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal agingMarwan N Sabbagh, Flora Shah, Richard T Reid, et al.Hippocampus|April 6, 2017
Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathwayIgnazio S Piras, Jonida Krate, Isabelle Schrauwen, et al.Molecular Neurodegeneration|July 17, 2009
Disassembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson's disease patientsZhenyu Zhong, Hikmet Nural, Ping He, et al.Journal of Neurochemistry|January 29, 2008
In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brainLiang Ye, Ana Velasco, Graham Fraser, et al.Current Alzheimer Research|May 1, 2013
Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier statusMichael Malek-Ahmadi, Thomas Beach, Aleksandra Obradov, et al.Journal of Neurochemistry|February 20, 2009
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologiesPaul W Thompson, Liang Ye, Jennifer L Morgenstern, et al.Pageof 2